Piperidine amides as modulators of chemokine receptor activity

Details Piperidine amides as modulators of chemokine receptor activity Piperidine amides as modulators of chemokine receptor activity

2006-01-10

2006-01-10

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S381000, C514S397000, C514S406000, C514S422000, C514S428000, C544S333000, C546S197000, C546S199000, C546S276400, C548S250000, C548S314700, C548S364100, C548S517000, C548S518000, C548S567000

Reexamination Certificate

active

06984651

ABSTRACT:
The present application describes modulators of CCR3 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.

REFERENCES:
patent: 4613695 (1986-09-01), Carlsson et al.
patent: 5352796 (1994-10-01), Hoeger et al.
patent: 5668151 (1997-09-01), Poindexter et al.
patent: 5847148 (1998-12-01), Jacobsen et al.
patent: 5880128 (1999-03-01), Doll et al.
patent: 5994364 (1999-11-01), Njoroge et al.
patent: 5998447 (1999-12-01), Stilz et al.
patent: 2614189 (1977-10-01), None
patent: 0685463 (1994-02-01), None
patent: 0842943 (1997-11-01), None
patent: 0842945 (1997-11-01), None
patent: 659743 (1998-06-01), None
patent: 0903349 (1999-03-01), None
patent: 915088 (1999-05-01), None
patent: 92/03410 (1992-03-01), None
patent: 9301167 (1993-01-01), None
patent: 93/06108 (1993-04-01), None
patent: 93/21172 (1993-10-01), None
patent: 95/09859 (1995-04-01), None
patent: 95/13069 (1995-05-01), None
patent: 95/24186 (1995-09-01), None
patent: 96/14317 (1996-05-01), None
patent: 96/16981 (1996-06-01), None
patent: 97/09329 (1997-03-01), None
patent: 97/12876 (1997-04-01), None
patent: 9714689 (1997-04-01), None
patent: 97/23458 (1997-07-01), None
patent: 97/24325 (1997-07-01), None
patent: 98/04247 (1998-02-01), None
patent: 98/11092 (1998-03-01), None
patent: 98/25604 (1998-06-01), None
patent: 98/31359 (1998-07-01), None
patent: 98/31669 (1998-07-01), None
patent: WO 98/53814 (1998-12-01), None
patent: 99/50238 (1999-10-01), None
patent: WO 99/54321 (1999-10-01), None
patent: 00/00477 (2000-01-01), None
patent: 00/35449 (2000-06-01), None
patent: 00/35451 (2000-06-01), None
patent: 00/35452 (2000-06-01), None
patent: 00/35453 (2000-06-01), None
patent: 00/35454 (2000-06-01), None
patent: 00/35876 (2000-06-01), None
patent: 00/35877 (2000-06-01), None
patent: WO 01/00206 (2001-01-01), None
Wyngaarden et al. “Cecil textbook of medicine” Saunders, p. 1397-98 (1983).
Ikegami et al. “Preparation of azepine . . . ” CA 135:137529 (2001).
Atwal et al., “Binding of ATP-Sensitive Potassium Channel (KATP) Openers to Cardiac Membranes: Correlation of Binding Affinities with Cardioprotective and Smooth Muscle Relaxing Potencies”, J. Med. Chem., vol. 41, pp. 271-275, 1998.
Michael Gutschow, “One-Pot Reactions of N-(Mesyloxy)phthalimides with Secondary Amines to 2-Ureidobenzamides, 2-Ureidobenzoic Acids, Ethyl 2-Ureidobenzoates, or Isatoic Anhydrides”, J. Org. Chem, vol. 64, pp. 5109-5115, 1999.
Jacobsen et al., Synthesis of a Series of Stromelysin-Selective Thiadiazole Urea Matrix Metalloprotease Inhibitors, Journal of Medicinal Chemistry, 1999, pp. 1525-1536, vol. 42, No. 9.
Freidinger et al., Novel Glutamic Acid Derived Cholecystokinin Receptor Ligands, Journal of Medicinal Chemistry, 1990, pp. 591-595, vol. 33, No. 2.
Capet et al., “Pyrrolidinines derivatives with a strong binding affinity for CCK and gastrin receptors”, CA 122:31320 (1994).
Adams et al., “Early trauma polymorphonuclear neutrophil responses to chemokines are associated with development of sepsis, pneumonia, and organ failure”, CA 136:261758 (2001).
Stedman's medical dictionary (2000), p. 897-898.
Harrison's principles of internal medicine (1994), p. 494-495.

Affiliated with

Also associated with

Rating

Piperidine amides as modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine amides as modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine amides as modulators of chemokine receptor activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3530721